This study investigates the safety of switching to an investigational medication after stopping another treatment called emicizumab. The purpose of this study is to understand how male participants with severe hemophilia A, a condition where blood does not clot properly, respond to this change in treatment. Hemophilia A is a …
This study investigates the use of prophylaxis treatment in patients with moderate or severe hemophilia A. Hemophilia A is a genetic disorder where the blood does not clot properly due to low levels of a protein called factor VIII. This study is being conducted in patients aged 12 to 50 …
